Biofloris Pharmaceuticals Private Limited

Founded in 2017 and headquartered in Tamil Nadu, India.

2017 | Salem, Tamil Nadu (India) | Active
Last Updated:

Biofloris Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 5.70 M
  • Company Age 7 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 11.05%
  • Profit Growth 94.15%
  • Ebitda 134.54%
  • Net Worth 43.28%
  • Total Assets 29.57%

About Biofloris Pharmaceuticals

Biofloris Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 September 2017 (Seven years and six months 16 days old ). Its registered office is in Salem, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.70 M, as per Ministry of Corporate Affairs (MCA) records.

Murugesan Chandrasekaran, Dhanasekaran Ravishankar, Balakrishnan Rajaganesan, and Six other members serve as directors at the Company.

Company Details

  • Location

    Salem, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U33300TZ2017PTC029531

  • Company No.

    029531

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    28 Sep 2017

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Coimbatore

Industry

Pharma
Company report

Biofloris Pharmaceuticals Private Limited

Explore comprehensive data for Biofloris Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Biofloris Pharmaceuticals?

Board Members (9)

NameDesignationAppointment DateStatus
Murugesan Chandrasekaran Country flag representing In Director 28-Sep-2017Current
Dhanasekaran Ravishankar Country flag representing In Director 28-Sep-2017Current
Balakrishnan Rajaganesan Country flag representing In Director 01-Dec-2017Current
Muthu Deivasigamani Country flag representing In Director 01-Dec-2017Current
Manickam Rajendran Country flag representing In Director 01-Dec-2017Current
Rajamanikkam Kandasamy Country flag representing In Director 01-Dec-2017Current

Financial Performance of Biofloris Pharmaceuticals.

Biofloris Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.05% increase. The company also saw a substantial improvement in profitability, with a 94.15% increase in profit. The company's net worth Soared by an impressive increase of 43.28%.

Biofloris Pharmaceuticals revenue growth over time
Biofloris Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
11.05%
Revenue from Operations
11.05%
Total Assets
29.57%
Profit or Loss
94.15%
Net Worth
43.28%
EBITDA
134.54%

What is the Ownership and Shareholding Structure of Biofloris Pharmaceuticals?

In 2023, Biofloris Pharmaceuticals had a public holding of 87.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Biofloris Pharmaceuticals?

Unlock and access historical data on people associated with Biofloris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Biofloris Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biofloris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofloris Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Biofloris Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Biofloris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Biofloris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Coimbatore.

  • Director Appointment

    Balakrishnan Rajaganesan was appointed as a Director was appointed as a Director on 01 Dec 2017 & has been associated with this company since 7 years 4 months .

  • Director Appointment

    Muthu Chellappan Deivasigamani was appointed as a Director was appointed as a Director on 01 Dec 2017 & has been associated with this company since 7 years 4 months .

  • Director Appointment

    Manickam Rajendran was appointed as a Director was appointed as a Director on 01 Dec 2017 & has been associated with this company since 7 years 4 months .

  • Director Appointment

    Murugesan Chandrasekaran was appointed as a Director was appointed as a Director on 28 Sep 2017 & has been associated with this company since 7 years 6 months .

Frequently asked questions

  • What is the Incorporation or founding date of Biofloris Pharmaceuticals Private Limited?

    Biofloris Pharmaceuticals Private Limited was incorporated on 28 Sep 2017.

  • What is authorized share capital and paid-up capital of Biofloris Pharmaceuticals Private Limited?

    The authorized share capital of Biofloris Pharmaceuticals Private Limited is ₹ 6.00 M and paid-up capital is ₹ 5.70 M.

  • Who are the current board members & directors of Biofloris Pharmaceuticals Private Limited?

    Currently 9 directors are associated with Biofloris Pharmaceuticals Private Limited.

    • Murugesan Chandrasekaran
    • Dhanasekaran Ravishankar
    • Balakrishnan Rajaganesan
    • Muthu Chellappan Deivasigamani
    • Manickam Rajendran
    • Rajamanikkam Kandasamy
    • Premkumar Asokumar
    • Subbarayagounder Palaniappan Sathish Kumar
    • Karthikeyan Arjunan

  • What is the registered address of Biofloris Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Biofloris Pharmaceuticals Private Limited is 147/153, Second Agraharam India, Salem, Tamil Nadu, 636003.

  • What is the corporate identification number (CIN) and company number of Biofloris Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Biofloris Pharmaceuticals Private Limited is U33300TZ2017PTC029531 and the company number is 029531 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Biofloris Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Biofloris Pharmaceuticals Private Limited has risen by 11.05%.

  • What change has been observed in the net worth of Biofloris Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Biofloris Pharmaceuticals Private Limited has experienced an upsurge of 43.28%.

  • When was the last Balance Sheet of Biofloris Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Biofloris Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors